Location History:
- Hokkaido, JP (2013)
- Sapporo, JP (2016 - 2022)
Company Filing History:
4 out of 34 
2 out of 110 
1 out of 140 Years Active: 2013-2022
Title: Kenjiro Kamiguchi: Innovator in Cancer Research
Introduction
Kenjiro Kamiguchi is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of molecular markers for cancer stem cells. With a total of four patents to his name, Kamiguchi's work is paving the way for advancements in cancer detection and treatment.
Latest Patents
Kamiguchi's latest patents focus on a molecular marker for detecting cancer stem cells in cell masses. This innovative marker can be identified in cancer stem cells but not in normal cells or other types of cancer cells. His patents include methods for determining the presence of cancer stem cells using this molecular marker, as well as kits designed for detection. Additionally, his work encompasses a polypeptide encoded by the molecular marker, antibodies that recognize specific epitopes, nucleic acids that inhibit the expression of the marker, and a nucleic acid vaccine derived from the marker.
Career Highlights
Throughout his career, Kenjiro Kamiguchi has worked with esteemed institutions such as Sapporo Medical University and Sumitomo Dainippon Pharma Co., Ltd. His research has been instrumental in advancing the understanding of cancer biology and improving diagnostic techniques.
Collaborations
Kamiguchi has collaborated with notable colleagues, including Toshihiko Torigoe and Yoshihiko Hirohashi. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Kenjiro Kamiguchi's work in cancer research exemplifies the impact of innovation in medical science. His patents and collaborations highlight his commitment to improving cancer detection and treatment methodologies.